Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis

Documenti analoghi

• Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
  di: Shu, Yanyun, et al.
  Pubblicazione: (2021)
• Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis
  di: Ni, Ping, et al.
  Pubblicazione: (2019)
• External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
  di: Cheung, Angela C., et al.
  Pubblicazione: (2018)
• Evaluation of the United Kingdom‐primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population
  di: Alomari, Mohammad, et al.
  Pubblicazione: (2019)
• Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
  di: Zimmer, Vincent, et al.
  Pubblicazione: (2016)